Navigation Links
Roger Graham Named President of Mylan Specialty
Date:6/24/2013

He began his career with Schering-Plough and, over nearly a decade, took on positions of increasing responsibility in the company's allergy, respiratory and oncology sales and marketing organizations.

Graham has a bachelor's degree in business administration from The University of Kansas and an MBA from Seton Hall University.

This press release includes statements that constitute "forward-looking statements," including with regard to the company's future growth and performance. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the impacts of competition; changes in economic and financial conditions of the company's business; the ability to attract and retain key personnel; uncertainties and matters beyond the control of management; and the other risks detailed in the company's filings with the Securities and Exchange Commission. The company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pha
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roger bridges the understanding gap for students with hearing loss
2. Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
3. $4 Co-pay on Kroger Premium Blood Glucose Test Strips
4. Kroger Announces Merger with Axium Pharmacy
5. Flu Shots Available Now at Krogers Family of Pharmacies and The Little Clinic
6. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
7. Graham Cooper Appointed Chief Financial Officer of Receptos
8. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
9. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
10. Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS
11. Baby Eva Named After Pioneering IVF Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... WASHINGTON , April 16, 2015 A drug ... the eyesight of people with multiple sclerosis (MS), according to ... American Academy of Neurology,s 67th Annual Meeting in ... "About half of people with MS experience at ... neuritis, in which the nerve carrying vision from the eye ...
(Date:4/16/2015)... 16, 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 2015 on Wednesday, May 6, 2015, following the close of ... investor conference call and live webcast on the same day ... and discuss the financial results.  To access ... under the "Investors" link.  Please log onto the webcast prior ...
(Date:4/16/2015)... Mallinckrodt plc (NYSE: MNK ), ... it has completed its acquisition of Ikaria, Inc. ... The Ikaria acquisition extends Mallinckrodt,s footprint in the ... critical care with INOMAX ® (inhaled nitric ... vulnerable patient population. It also accelerates Mallinckrodt,s rapid ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... Technologies, Inc. (NYSE Amex: PTN ) today announced ... Palatin,s request to begin a Phase 2A proof-of-concept human trial ... administered formulation of PL-3994, an NPR-A agonist compound, in development ... "We are excited about the prospect of advancing PL-3994 into ...
... 3, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... preventive vaccines against cancers and infectious diseases, announced today that ... company overview at the ROTH 23rd Annual Growth Stock Conference ... A live and archived webcast will be accessible ...
Cached Medicine Technology:FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for Asthma 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 3
(Date:4/18/2015)... Patients who undergo radiation for a hematologic cancer ... but the disease is likely to differ in some ... Surviving Mesothelioma has just posted the details of this ... read it now. , Scientists from China, the ... who had both a hematologic cancer (like lymphoma or ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch ... at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... , In a turbulent world, people may find themselves ... always be their first move, but some situations can be ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable assisted ... on April 20 with a day full of activities ... soul. , The community, which is located at 605 ... all incomes, including those on Medicaid, who need some ... is observed every April and highlights the communities within ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory foam ... help a broader range of people plagued by pain. ... most common visitors to doctors. , “The ERGO-Pedic Comfort ... relieve sitting pain. Then, only a couple months after ... later, we began getting questions from those customers, asking ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2
... MONDAY, Feb. 20 (HealthDay News) -- Alcohol use disorders are ... reveals. The online, anonymous poll indicated that 15 percent ... nearly 14 percent of male surgeons and 26 percent of ... 12 percent figure typically cited for alcohol abuse rates among ...
... Feb. 19 (HealthDay News) -- Even though a colonoscopy is ... many people have unfounded worries about the test and avoid ... tool that allows us to see how healthy our insides ... and a gastroenterologist at Saint Louis University, said in a ...
... Substituting smokeless tobacco products can save smokers, lives, ... That is the message Brad Rodu, D.D.S., professor ... of Medicine and the Endowed Chair in Tobacco Harm ... at the Annual Meeting of the American Association for ...
... --- Alzheimer,s disease drugs now being tested in clinical ... new Northwestern Medicine research. A study with mice suggests ... neurons to be miswired and interfering with their ability ... from the scientist whose original research led to the ...
... SATURDAY, Feb. 18 (HealthDay News) -- Two factors -- a ... critical to quality of life for disabled elderly people, according ... seniors rate their quality of life as "fair to very ... seniors (white, black, Hispanic, and Chinese American) who were interviewed ...
... 17 (HealthDay News) -- Decades-old assumptions about the odds of reaching very ... for many seniors, a new study finds. At issue is how ... A team of researchers now believe that death rates continue to rise ... bit. The findings could lead to new estimates of life span, ...
Cached Medicine News:Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 2Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 3Health News:15% of U.S. Surgeons Report Drinking Problems in Survey 4Health News:Worries About Colonoscopy Unfounded: Study 2Health News:UofL research shows substituting with smokeless tobacco saves lives 2Health News:Alzheimer's drugs may have adverse side effects 2Health News: Disabled Elderly Say They Want Dignity, Control 2Health News:Living to 100 May Be Tougher Than You Think 2
... is an endoscopic urethral implant for ... Upon implantation, the Tegress™ Implant solution ... in a Dimethyl Sulfoxide (DMSO) carrier ... reinforces the integrity of the urethras ...
... (VZ) test system is intended ... detection of VZ IgG antibody ... indirect fluorescent antibody (IFA) technique. ... confirm a recent infection or ...
... Captia™ Varicella-Zoster Virus (VZV) IgM ... intended for the detection of ... in human serum as an ... primary infection or reactivation. For ...
... Biotech Captia™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked ... detection and quantitative determination of IgG antibody ... specimens may be used for the determination ... convalescent, may be used to demonstrate seroconversion ...
Medicine Products: